HealthStream, Inc. (HSTM) - NASDAQ
  • Yesterday, 4:32 PM
    • HealthStream (NASDAQ:HSTM): Q2 EPS of $0.04 misses by $0.05.
    • Revenue of $54.8M (-0.0% Y/Y) misses by $2M.
    • Press Release
    | Yesterday, 4:32 PM
  • Fri, Jul. 1, 10:08 AM
    • Invitae (NYSE:NVTA) initiated with Hold rating with an $8.50 (18% upside) price target by Benchmark.
    • Jazz Pharmaceuticals (NASDAQ:JAZZ) initiated with Outperform rating and $190 (33% upside) price target by BMO.
    • Pacira Pharmaceuticals (NASDAQ:PCRX) initiated with Underperform rating and $36 (4% upside) price target by BMO.
    • Mallinckrodt (NYSE:MNK) initiated with Outperform rating and $84 (35% upside) price target by BMO.
    • Horizon Pharma plc (NASDAQ:HZNP) initiated with Outperform rating and $29 (71% upside) price target by BMO.
    • Regeneron Pharmaceuticals (NASDAQ:REGN) initiated with an Outperform rating and $400 (13% upside) price target by Bernstein.
    • Biogen (NASDAQ:BIIB) initiated with an Outperform rating and $282 (15% upside) price target by Bernstein.
    • Amgen (NASDAQ:AMGN) initiated with Market Perform rating and $161 (5% upside) price target by Bernstein.
    • Lannett Company (NYSE:LCI) initiated with Hold rating and $26 (5% upside) price target by Deutsche Bank.
    • OpGen (NASDAQ:OPGN) initiated with Buy rating and $2.50 (66% upside) price target by Rodman & Renshaw.
    • Valeant Pharmaceuticals (NYSE:VRX) initiated with Market Perform rating and $26 (22% upside) price target by BMO.
    • Neurocrine Biosciences (NASDAQ:NBIX) initiated with Outperform rating and $80 (75% upside) price target by H.C. Wainwright.
    • Healthstream (NASDAQ:HSTM) initiated with Outperform rating and $30 (12% upside) price target by Barrington Research.
    • Neurometrix (NASDAQ:NURO) initiated with Buy rating and $4.50 (165% upside) price target by Rodman & Renshaw.
    • Vascular Biogenics (NASDAQ:VBLT) initiated with Buy rating and $11 (139% upside) price target by H.C. Wainwright.
    | Fri, Jul. 1, 10:08 AM | 6 Comments
  • Mon, Apr. 25, 4:28 PM
    • HealthStream (NASDAQ:HSTM): Q1 EPS of $0.05 misses by $0.03.
    • Revenue of $54.1M (+13.3% Y/Y) beats by $0.07M.
    • Press Release
    | Mon, Apr. 25, 4:28 PM
  • Sun, Apr. 24, 5:35 PM
    | Sun, Apr. 24, 5:35 PM | 13 Comments
  • Fri, Apr. 1, 10:53 AM
    • Relypsa (RLYP -2.5%) initiated with Buy rating and $26 (98% upside) price target by Brean Capital.
    • HealthStream (HSTM +0.2%) initiated with Outperform rating and $27 (22% upside) price target by FBR Capital.
    • Syndax Pharmaceuticals (SNDX +0.8%) initiated with Overweight rating and $22 (64% upside) price target by Morgan Stanley. Initiated with Buy rating and $24 (79% upside) price target by Citigroup.
    • SCYNEXIS (SCYX) initiated with Buy rating and $16 (295% upside) price target by Brean Capital.
    • AveXis (AVXS -4.9%) initiated with Buy rating and $60 (124% upside) price target by Chardan Capital.
    | Fri, Apr. 1, 10:53 AM
  • Fri, Feb. 19, 8:22 AM
    • MacroGenics (NASDAQ:MGNX) initiated with Buy rating and $36 (110% upside) price target by Janney Capital.
    • Alcobra (NASDAQ:ADHD) initiated with Buy rating with a $10 (95% upside) price target by Jefferies.
    • Valeant Pharmaceuticals (NYSE:VRX) initiated with Buy rating and $150 (60% upside) price target by Rodman & Renshaw.
    • Ocular Therapeutix (NASDAQ:OCUL) upgraded to Overweight from Equal Weight by Morgan Stanley. Price target maintained at $15 (81% upside).
    • HealthStream (NASDAQ:HSTM) upgraded to Buy from Hold with a price target of $25 (16% upside) by Needham.
    • Juno Therapeutics (NASDAQ:JUNO) upgraded to Buy from Neutral by Guggenheim.
    • Regeneron Pharmaceuticals (NASDAQ:REGN) upgraded to Neutral from Sell by Chardan Capital. Price target lowered to $375 (3% downside risk) from $400.
    • Community Health Systems (NYSE:CYH) downgraded to Market Perform from Outperform by Avondale. Price target lowered to $18 (20% upside).
    | Fri, Feb. 19, 8:22 AM | 7 Comments
  • Tue, Feb. 16, 4:34 PM
    • HealthStream (NASDAQ:HSTM): Q4 EPS of $0.06 beats by $0.02.
    • Revenue of $55.9M (+22.6% Y/Y) beats by $1.83M.
    • Press Release
    | Tue, Feb. 16, 4:34 PM
  • Mon, Feb. 15, 5:35 PM
    | Mon, Feb. 15, 5:35 PM | 4 Comments
  • Oct. 19, 2015, 4:31 PM
    • HealthStream (NASDAQ:HSTM): Q3 EPS of $0.08 beats by $0.03.
    • Revenue of $53.8M (+20.4% Y/Y) beats by $1.48M.
    | Oct. 19, 2015, 4:31 PM
  • Oct. 18, 2015, 5:35 PM
    | Oct. 18, 2015, 5:35 PM | 9 Comments
  • Jul. 20, 2015, 4:35 PM
    • HealthStream (NASDAQ:HSTM): Q2 EPS of $0.05 misses by $0.02.
    • Revenue of $52.1M (+22.6% Y/Y) beats by $0.89M.
    | Jul. 20, 2015, 4:35 PM
  • Jul. 19, 2015, 5:35 PM
    | Jul. 19, 2015, 5:35 PM | 12 Comments
  • May 19, 2015, 6:54 PM
    • As part of a change in analyst coverage for cloud software stocks, Needham's Scott Berg has launched coverage on Workday (NYSE:WDAY) and HealthStream (NASDAQ:HSTM) at Buy, upgraded Cornerstone OnDemand (NASDAQ:CSOD) to Strong Buy, and upgraded Ultimate Software (NASDAQ:ULTI) to Buy after the close. Though their product lines differ, all 4 companies have exposure to the cloud HR/talent management space.
    • Berg on Workday: "[W]e believe WDAY has the combination that growth investors seek: large market, well positioned product versus industry megatrends, and a financial model that yields significant revenue visibility ... Although we believe the company's current valuation assumes almost flawless near-term sales execution to further expand its valuation multiples, we believe its execution within a HCM market exhibiting high demand creates a positive risk/reward scenario..." The remarks come ahead of Workday's May 26 FQ1 report.
    • Berg on HealthStream: "We believe HealthStream uniquely benefits from two significant mega-trends; 1) the strong secular adoption rates within the Talent Management Enterprise Software subsector, and also 2) an environment that is increasingly regulated, requiring its products’ end users to evaluate competencies and train employees on a more frequent basis." The cloud healthcare software firm is a month removed from posting a Q1 beat.
    • WDAY +0.7% AH to $91.28. CSOD +1.9% to $32.44. ULTI +1.2% to $170.29. HealthStream hasn't yet moved AH.
    | May 19, 2015, 6:54 PM
  • Apr. 20, 2015, 4:31 PM
    • HealthStream (NASDAQ:HSTM): Q1 EPS of $0.10 beats by $0.03.
    • Revenue of $47.2M (+23.1% Y/Y) beats by $1.58M.
    | Apr. 20, 2015, 4:31 PM
  • Apr. 19, 2015, 5:35 PM
    | Apr. 19, 2015, 5:35 PM | 2 Comments
  • Feb. 19, 2015, 12:46 PM
    | Feb. 19, 2015, 12:46 PM | 1 Comment
Company Description
HealthStream, Inc. provides SaaS-based workforce development solutions and research/patient experience solutions for healthcare organizations-all designed to assess and develop the people that deliver patient care which, in turn, supports the improvement of business and clinical outcomes. The... More
Sector: Technology
Industry: Internet Information Providers
Country: United States